Enterprise Solutions Webinars

  1. Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics 1/22/2025

    Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

  2. Growing A Sustainability Culture Across An Expanding CDMO Network 1/15/2025

    Peter Skals, Head of Global Sustainability, shares how the company is integrating its climate and ESG strategy while simultaneously expanding its CDMO network and reducing its CO2 footprint.

  3. How Does A Successful Client-CDMO Partnership Meet Challenges? 1/3/2025

    Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski explain the importance of transparency and collaboration when encountering manufacturing speed bumps.

  4. Engaging A CDMO Partner With Life Biosciences' Jerry McLaughlin 1/3/2025

    Jerry McLaughlin explains the vetting process he used to select Forge Biologics as a CDMO partner.

  5. Life Biosciences' Successful Partnership With Forge Biologics 1/3/2025

    Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski discuss their companies’ partnership, Life’s pipeline, and Columbus’ biotech hub.

  6. Assemblies Are Not Particulate Free, Strategies For Risk Mitigation 12/19/2024

    As single-use technologies gain prominence in critical applications, the scrutiny around particulate contamination intensifies due to its potential impact on drug product quality, safety, and patient outcomes.

  7. How Standardized Extractables Data Support E&L Risk Assessment 12/19/2024

    Explore E&L evaluations, USP <665>, supplier-provided extractables data, and collaborative strategies to mitigate risks in Single-Use Systems for biopharmaceutical manufacturing processes.

  8. Evaluating USP 665 For Extractables Testing And Reducing Animal Testing For Biological Reactivity 12/19/2024

    Explore evolving compendial methods, USP <665>, and transitioning to cell-based assays for extractables, leachables, and biological reactivity in single-use pharmaceutical manufacturing.

  9. Challenges Using Multiple Single-Use Systems Functionality Versus Extractables And Leachables 12/19/2024

    Explore a risk assessment of extractables, evaluating single-use components, and addressing complexities in manufacturing processes, with a case study highlighting compatibility and patient safety concerns.

  10. Streamline Bioprocesses While Meeting The Demands Of Modern Cell Culture 12/13/2024

    Xcellerex™ X-platform bioreactors offer modular, user-friendly designs with optimized scalability, adaptable automation, and standardization, enhancing productivity in pilot and cGMP cell culture operations.